Inventor

EKSTEROWICZ JOHN

US24 patents

⚠️ This page may combine multiple inventors who share the name “EKSTEROWICZ JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ORIC PHARMACEUTICALS INC

18 patents

US11028120B2Jun 8, 2021

CD73 inhibitors

ORIC PHARMACEUTICALS INC10 citations93

US12018043B2Jun 25, 2024

CD73 inhibitors

ORIC PHARMACEUTICALS INC6 citations85

US11325938B2May 10, 2022

CD73 inhibitors

ORIC PHARMACEUTICALS INC9 citations85

US11530236B2Dec 20, 2022

CD73 inhibitors

ORIC PHARMACEUTICALS INC4 citations83

US11130778B2Sep 28, 2021

CD73 inhibitors

ORIC PHARMACEUTICALS INC8 citations83

US11129841B2Sep 28, 2021

CD73 inhibitors

ORIC PHARMACEUTICALS INC7 citations82

US10472387B2Nov 12, 2019

Inhibitors of glucocorticoid receptor

ORIC PHARMACEUTICALS INC2 citations73

US11377469B2Jul 5, 2022

CD73 inhibitors

ORIC PHARMACEUTICALS INC5 citations71

US12577272B2Mar 17, 2026

CD73 inhibitors

ORIC PHARMACEUTICALS INC0 citations62

US12454544B2Oct 28, 2025

CD73 inhibitors

ORIC PHARMACEUTICALS INC0 citations62

US11807658B2Nov 7, 2023

CD73 inhibitors

ORIC PHARMACEUTICALS INC1 citations62

US11576922B2Feb 14, 2023

CD73 inhibitors

ORIC PHARMACEUTICALS INC1 citations61

US11124537B2Sep 21, 2021

Inhibitors of glucocorticoid receptor

ORIC PHARMACEUTICALS INC1 citations61

US12544391B2Feb 10, 2026

CD73 inhibitors

ORIC PHARMACEUTICALS INC0 citations51

US11208432B2Dec 28, 2021

Inhibitors of glucocorticoid receptor

ORIC PHARMACEUTICALS INC0 citations51

US11110103B2Sep 7, 2021

Inhibitors of glucocorticoid receptor

ORIC PHARMACEUTICALS INC0 citations51

US10836789B2Nov 17, 2020

Inhibitors of glucocorticoid receptor

ORIC PHARMACEUTICALS INC0 citations51

US10723759B2Jul 28, 2020

Inhibitors of glucocorticoid receptor

ORIC PHARMACEUTICALS INC0 citations51

AMGEN INC

4 patents

US9593129B2Mar 14, 2017

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

AMGEN INC5 citations83

US9296736B2Mar 29, 2016

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

AMGEN INC7 citations83

US9376425B2Jun 28, 2016

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

AMGEN INC12 citations82

US8980903B2Mar 17, 2015

Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors

AMGEN INC0 citations51

CONNORS RICHARD V

2 patents

US8841312B2Sep 23, 2014

Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors

CONNORS RICHARD V6 citations80

US8389533B2Mar 5, 2013

Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors

CONNORS RICHARD V3 citations60